SHREE GANESH REMEDIES LTD (SGRL) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Incorporated in 1995, Shree Ganesh Remedies Ltd is a manufacturer of Pharmaceutical Drug Intermediates for API & Fine Chemicals[1]

SGRLUpdated 18 Aug 2026, 16:46

Shree Ganesh Remedies Ltd

Market Cap

₹673Cr.

Current Price

₹524

High / Low

₹759/381

Stock P/E

43.6

Book Value₹127
Dividend Yield0.00%
ROCE14.6%
ROE11.5%
Face Value₹10.0

About

Incorporated in 1995, Shree Ganesh Remedies Ltd is a manufacturer of Pharmaceutical Drug Intermediates for API & Fine Chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days931331367810110499941125975109
Inventory Days13213010310212556206132138156223209
Days Payable43329043753910192118516182
Cash Conversion Cycle183232149137151120205134133164238236
Working Capital Days16020217212814510215813312289111169
ROCE %16%12%26%27%27%33%28%33%22%28%19%15%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 18 August 2026 at 16:46


Designed & Shipped by Harshit Bansal